CRISPR Therapeutics saw the highest growth of 149% in patent filings in February and 199% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 45% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of CRISPR Therapeutics‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

CRISPR Therapeutics has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with 11 publications in Q1 2024

The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 61% of filings. The World Intellectual Property Organization(WIPO), United States(US), Taiwan(TW), and Australia(AU) patent Office are among the top ten patent offices where CRISPR Therapeutics is filings its patents. Among the top granted patent authorities, CRISPR Therapeutics has 67% of its grants in United States(US) and 17% in Australia(AU).

Regeneron Pharmaceuticals and Massachusetts Institute of Technology could be the strongest competitors for CRISPR Therapeutics

In terms of grant share, CRISPR Therapeutics stands in fifth position among its competitors. Regeneron Pharmaceuticals and Massachusetts Institute of Technology secured the top positions according to recent patent publication data.

Patents related to nanomedicine and genomics lead CRISPR Therapeutics's portfolio

CRISPR Therapeutics has the highest number of patents in nanomedicine followed by, genomics and cell & gene therapy. For nanomedicine, nearly 44% of patents were filed and 25% of patents were granted in Q1 2024.

Meningitis related patents lead CRISPR Therapeutics portfolio followed by glaucoma, and cardiovascular disease

CRISPR Therapeutics has highest number of patents in meningitis followed by glaucoma, cardiovascular disease, friedreich ataxia, and pain. For meningitis, nearly 10% of patents were filed and 25% of patents were granted in Q1 2024.

For comprehensive analysis of CRISPR Therapeutics's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.